Nikhil Luktuke

Responsible for Global Business Development including licensing of products, strategic investment-backed collaborations and co-development initiatives and tactical market access projects.

Head of Sales for Europe, Middle East & Africa and Asia - Pacific markets. Lead an overall team of 7 (including people managers) to drive the largest business unit for the company. P&L responsibility including achieving revenue objectives (for both FDFs and APIs), protecting base business and business development through negotiating & executing licensing and supply contracts to secure future business.

Lead for business development & licensing for APAC and developing a long range plan for the region. Led a team of 2 direct reports specializing in China and in Business Intelligence

Overall responsibility of product portfolio, pipeline planning and In & Out licensing of products. New market entry strategy and execution. Long range planning for the Asia –Pacific Business. P&L responsibility for new markets. > Licensed out a Novel research product, Ryaltris™, for i) China and ii) Korea > Expanded reach of Glenmark’s products to China through licensing agreements; several additional discussions in advanced stage > Extensive market and portfolio analysis, development of a 3 year filing pipeline, leading to a 5 year plan of over $100mn for a region at a 24% CAGR

> Licensed out a Novel research product, Ryaltris™, for Australia and New Zealand > Expanded reach of Glenmark’s products to Indonesia and Australia through licensing agreements > Roadmap and strategy created and implemented for Thailand and Hong Kong > Several in-licensing and out-licensing projects executed > Developed well researched in-licensing strategy and target pipeline expected to contribute to the Long Range Plan

Build and own Business Development and operations for this new strategic business for Biocon: identify drugs to in-license for JV in UAE, out-licence assets in MENA region > In-licensed a novel product to augment the oncology portfolio by 11% in sales revenue

Headed an 8 member team responsible for strategic and tactical direction for the division, including budget phasing and allocation, new product identification, inventory management, financial tracking, sales force effectiveness and hiring decisions (annual revenue $10mn)

Pan-India marketing for a novel oncology product, Ixempra (ixabepilone), with annual revenues of $2mn > Conceptualized and implemented an India marketing strategy, locally adapting and refining the global strategy, that led to a streak of 9 months of continuous growth, countering a decline in sales over previous 6 months, resulting in a 12% YoY growth. - Recognized by several region heads and conferred ‘BMS Star Award’

> Developed a consumer interaction-intensive marketing strategy to drive trials for Women’s Horlicks & Horlicks Lite, line extensions of Horlicks (a $200mn Health Food Drink in India) through conducting dip-stick research at 5 major malls, reaching out to over 400 opinions > Designed a modern trade structured, cross-marketing strategy with an apparel major assessed to increase sales by $2mn for Women’s Horlicks

Start-up in Human Capital Management established in 2007 Headed business development across SBUs, enlisting new clients while expanding existing business volumes > Successfully negotiated 7 contracts within 2 months (financial and telecom companies) > Rated the best performer, was offered a Pre-MBA offer as Business Head – Recruitment

> Planned & executed 3 simultaneous research projects aimed at inhibiting growth and metastasis of breast carcinomas > Identified a breakthrough 147 putative regulators of breast cancer through bioinformatic analysis of the entire human genome Publication: AKT Alters Genome-Wide Estrogen Receptor α Binding and Impacts Estrogen Signaling in Breast Cancer; Mol. Cell. Biol. Dec 2008

Research focussed on aluminium transporters in yeast > Created yeast strains containing mutant Alr1 gene > Harvested proteins to study effect of these mutations

Project on Phosopholipase C family in Arabidopsis thaliana > Identified 6 putative PC-PLC genes in A.t. > Preliminary analysis at two levels on those genes a) Overexpresssed the genes in bacteria to study characteristics of the protein b) Created mutants lacking one gene and crossed them to produce double and triple mutants